APOA2 and myeloid sarcoma: Based on our results, we conclude that the complex MS pathophysiology disrupts the negative associations of HDL cholesterol and phospholipid content with FMD, as well as of HDL phospholipid content with EL observed in HV, but promotes the association of EL with small dense HDL, which contains apoA-II.